These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New NRC guidance on release of patients after 131I treatment. J Nucl Med; 2008 Jul; 49(7):16N. PubMed ID: 18587081 [No Abstract] [Full Text] [Related]
6. Oxyphenbutazone-induced parotitis. Gross L Ann Intern Med; 1969 Jun; 70(6):1229-30. PubMed ID: 5789512 [No Abstract] [Full Text] [Related]
7. Parotitis due to ritodrine tocolytic treatment for preterm labor. Marioni G; Marchese-Ragona R; Ottaviano G; Campobasso C; Staffieri A Otolaryngol Head Neck Surg; 2005 Apr; 132(4):665-6. PubMed ID: 15806068 [No Abstract] [Full Text] [Related]
8. Epiphora after radioactive iodine therapy in a low-risk patient. Song H; Jeong J; Ju Koh M Clin Nucl Med; 2015 Jun; 40(6):536-7. PubMed ID: 25674875 [TBL] [Abstract][Full Text] [Related]
14. A review and assessment of drug-induced parotitis. Brooks KG; Thompson DF Ann Pharmacother; 2012 Dec; 46(12):1688-99. PubMed ID: 23249870 [TBL] [Abstract][Full Text] [Related]
15. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective. Clarke SE Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878 [No Abstract] [Full Text] [Related]
16. [Risk-group patients due to the administration of iodine and gadolinium preparations for diagnostic clinical study]. Napolov IuK; Korobkova IZ; Maslennikov MA Vestn Rentgenol Radiol; 2011; (1):29-40. PubMed ID: 21598470 [TBL] [Abstract][Full Text] [Related]